InvestorsHub Logo
Followers 17
Posts 899
Boards Moderated 0
Alias Born 09/28/2014

Re: None

Thursday, 04/20/2023 5:35:45 PM

Thursday, April 20, 2023 5:35:45 PM

Post# of 701433
As I am out of my league among the many selfless contributors on this msg board, I am unable to evaluate this latest news from INmune: So…intellects and professionals please give it a go.

Note: (1) Immune Ventures mentioned in the 8K was founded by Mark Lowdell, CMO/CSO of INmune Bio. (2) INKmune, subject of the 8K: INKmune, the company’s lead product, primes patient’s NK cells (natural killer cells) to kill cancer. (3) Mark Lowdell is also a Director, Autolomous.

https://www.inmunebio.com/tmp/cfc740430ec7c787d8fd3cfe64021d72283f69ca3d62fc1b7291988cc7818622.pdf
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News